Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplierIndia's regulatory hurdles slow down early-stage drug trials significantly. This complexity causes Indian companies to conduct crucial firs...
From hunger to obesity: Developing world faces growing threat to child healthChildhood obesity is rapidly increasing in developing nations, creating a significant health challenge. This epidemic is now outpacing unde...
GLP-1 drugs create new market for collagen, protein and beauty products in IndiaThe rising use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro is creating a new consumer market in India, with companies developin...
In 2019, research began with users of anti-diabetes treatment medicines, now study shows side effect could be hair lossDiabetes treatment: The researchers said while the study was a rigorous one, based on high quality data from a large representative cohort,...
Nestle looks to develop new products to serve users of weight-loss drugsNestle is developing specialized products for GLP-1 weight-loss drug users. Artificial intelligence aids in analyzing research and identify...
Sohail Khan reveals reason behind his 12-kg weight loss on The Alliance, says “no ozempic, no fat burners”Sohail Khan candidly shared his reality show journey, highlighting his significant weight loss and the challenges he faced, including a sto...
What is 'food divorce'? An Emerging trend where couples cook and eat separately, know its impact on relationshipsIn today’s evolving lifestyle, many couples are experiencing what is known as food divorce, where they choose to shop, cook, and dine separ...
Novo CEO says setbacks demand faster research, acquisitions as investors fret over pipelineNovo Nordisk CEO Mike Doustdar said the company will speed up research and pursue smaller acquisitions to strengthen its drug pipeline afte...
The whey revolution: America's protein craze is changing dairy economicsWhey protein, once a cheesemaking byproduct, is now highly sought after by consumers. Social media trends and dietary advice are driving th...
Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug adsNovo Nordisk is seeking a court injunction to stop Eli Lilly's drug advertisements. The Danish company claims Lilly's ads mislead consumers...
Cipla in no hurry to launch semaglutide as Yurpeak gains tractionCipla is focusing on its tirzepatide brand Yurpeak in India's obesity market. Yurpeak has become the second largest GLP-1 product since its...
Novo Nordisk sues Eli Lilly, accusing it of false advertising of weight-loss drugNovo Nordisk has sued Eli Lilly in a U.S. court. The Danish company accuses Lilly of false advertising for its weight-loss medicines. Novo ...
Wegovy, Ozempic regain weight as Indian generics fall behindNovo Nordisk's weight-loss drugs are regaining market share from Indian generics. Innovator brands show steady month-on-month sales growth,...
Have you taken Ozempic? Tamannaah Bhatia’s fitness trainer Siddhartha Singh reveals 3 secrets to keep the weight offCelebrity trainer Siddhartha Singh, who trains Tamannaah Bhatia, warns that Ozempic's real challenge begins post-weight loss. He stresses t...
Is Ozempic the new Hollywood secret? Amanda Bynes reveals weight loss goal as studies link drug to lower dementia riskAmanda Bynes Ozempic weight loss journey is making headlines as the former Nickelodeon star revealed plans to lose over 40 pounds using the...
Elon Musk admits that he used Ozempic to lose weight; here's why the drug is controversialElon Musk revealed that he used the weight-loss drug Ozempic, sparking debate.
Headline: 5 Actors Who Have Openly Talked about Taking Ozempic for Weight LossHollywood actors are weighing on with their opinions on the weight-loss drug Ozempic and questioning the craze for getting thinner.